Aspira Pathlab to Raise ₹65 Cr via Rights Issue

Aspira Pathlab & Diagnostics Ltd announced its Board of Directors has approved a Rights Issue to raise up to ₹65 crore. The funds will be raised through equity or convertible instruments, subject to shareholder and regulatory approvals. A dedicated Rights Issue Committee has been formed to manage the process, including determining the record date, issue price, entitlement ratio, and appointing intermediaries. The meeting where these decisions were made took place on September 12, 2026.